Physician profile
Mark Ovsiowitz
NPI 1881712370
$1,365.81
in general payments reported to CMS, 2019-2025
10 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2022: $57.95 · 2023: $729 · 2024: $102 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,015 · Education: $22.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,014.65 |
| Education | $22.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $381.10 | 2019-2024 | Hemospray, Echotip, Instinct |
| Olympus America INC. | $269.17 | 2023-2024 | Evis Exera III Video System Center, Evis Exera III Colonovideoscope |
| Fujifilm Healthcare Americas Corporation | $150.00 | 2023 | Fujifilm |
| Genzyme Corporation | $144.95 | 2025 | |
| Allergan, INC. | $132.37 | 2019 | |
| Boston Scientific Corporation | $120.25 | 2019 | |
| Ardelyx, INC. | $61.26 | 2025 | Ibsrela |
| Apollo Endosurgery US INC | $57.95 | 2022 | |
| Abbvie INC. | $26.60 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $22.16 | 2023 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Ovsiowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.